Ashiq Mubarack

Item: Ashiq Mubarack
Rating: 0.88
Author: StockAnalysis.com

Stock Analyst at Citigroup

(0.88)

# 3,891

Out of 5,064 analysts

Total ratings

66.67%

Success rate

-18.49%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$150 → $125	$27.30	+357.88%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$3.82	+109.42%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $150 → $125

Current: $27.30

Upside: +357.88%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $3.82

Upside: +109.42%